Abiopharma

🔍 Fenger Michael J. (Director)

Company: Zoom Communications, Inc. (ZM)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 3,583 shares of Class A Common Stock (Direct)
  Date: 2026-06-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,321.00 | transaction_form_type: 4
• Sold 3,583 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-10 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 3,012 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,012.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer's Class A Common Stock.
• F2: The reporting person received an award of restricted stock units, 100% of which will vest on the first anniversary date of the grant (or, if sooner, the day immediately preceding the next annual meeting that occurs following the grant date).